Brain scan surveillance trial aims to catch metastases early in HER2+ breast cancer
NCT ID NCT07503717
First seen Apr 14, 2026 · Last updated May 17, 2026 · Updated 6 times
Summary
This study looks at whether it's possible to routinely scan the brain in people with HER2-positive metastatic breast cancer to find hidden brain tumors early. About 69 participants will get a baseline brain MRI, and if no tumors are found, they are randomly assigned to either follow-up scans or standard care (no routine scans). The goal is to see if patients are willing to join and if early detection is practical.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beaumont RCSI Cancer Centre
RECRUITINGBeaumont, Ireland
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.